Anna Mowry serves as Executive at Nautilus Biotechnology, Inc., where they oversee executive responsibilities. Since joining the company, Anna Mowry has executed 4 insider transactions totaling $259.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 19, 2022 involved purchasing 17,500 shares valued at $40.3K.
Anna Mowry currently holds 56,750 shares of Nautilus Biotechnology, Inc. (NAUT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anna Mowry has been a net buyer of NAUT stock. They have purchased $259.0K and sold $0 worth of shares.
Anna Mowry's most recent insider trade was on Aug 19, 2022, when they purchased 17,500 shares at $2.30 per share.
Get notified when new Form 4 filings are submitted
| $2.75 |
| Discretionary |
| Nov 24, 2021 | NAUT | $68.7K | Purchase | 15,000 | $4.58 | Discretionary |
| Aug 12, 2021 | NAUT | $134.9K | Purchase | 17,500 | $7.71 | Discretionary |